ArticleAnnals of pediatric cardiology
Analysis of various electrocardiographic and echocardiographic parameters in beta thalassemia patients with iron overload.
Article in Annals of pediatric cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiac magnetic resonance imaging (MRI) T2* is the gold standard investigation for predicting cardiac iron overload. Being costly and resource-limited, other investigations that are cost-effective and easily available are needed. Materials and Methods: We studied various electrocardiographic and echocardiographic parameters of transfusion-dependent thalassemia patients between 2022 and 2024 in our tertiary pediatric cardiac center in southern India. Results: Among our 50 patients of the age group 8 years-30 years (mean age group: 19.9 years ± 5.57), 62% of patients were males. Ninety-eight percent of our patients were asymptomatic, though 32% had MRI evidence of severe iron overload. Twenty-two percent of them had ferritin of more than 5000 µg/dL. There was a significant difference in Conclusions: Regular follow-up with tracking of the electrocardiographic and echocardiographic parameters can be used as an effective screening to guide timing for cardiac MRI and titrate chelation therapy. Early identification of iron overload, prompt initiation of chelation therapy, and ensuring adequate compliance with medical treatment, along with titration of chelation based on serial assessments, play a major role in improving the quality of life and lifespan for these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.